How big is that market, if PBT2 becomes one of the standard treatments before anasthesia. I think very big, but have not sen any figures.
The lead author of that study, Travis Craddock Phd, was also one of the co authors on the recent landmark paper with Tanzi on Tau/Zn- hypothesis(spotted by Pivalde on YMB), so I am sure he is well aware of the advantages of PBT2 over other treatments.
http://www.pranabio.com/downloads/Media%20Releases/Media%20Releases%202012/March%2026%202012%20PLoS%20Journal%20Publishes%20Model%20Of%20AD.pdf
wow, this is news, post-anesthesia dementia, page-2
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
-0.001(12.5%) |
Mkt cap ! $18.62M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $18.65K | 5.305M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 50 | 57052005 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 125915200 | 27 |
View Market Depth
| Last trade - 14.28pm 29/08/2024 (20 minute delay) ? |
| ATH (ASX) Chart |